Mariapaola Cucinotta

Mariapaola Cucinotta

Auto-generated profile, based on publicly available information

Mariapaola Cucinotta

Department of Biomedical Sciences, Dentistry and Morphological and Functional Images, University of Messina, Messina, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
NINatasha Irrera
Natasha Irrera
MCMariapaola Cucinotta
Mariapaola Cucinotta
Giovanni PallioGiovanni Pallio
Giovanni Pallio
FMFederica Mannino
Federica Mannino
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Oxidative stress is a phenomenon caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells and tissues and the ability of a biological system to detoxify these reactive products. ROS can play, and in fact they do it, several physiological roles (i.e., cell signaling), and they are normally generated as by‐products of oxygen metabolism; despite this, environmental stressors (i.e., UV, ionizing radiations, pollutants, and heavy metals) and xenobiotics (i.e., antiblastic drugs) contribute to greatly increase ROS production, therefore causing the imbalance that leads to cell and tissue damage (oxidative stress). Several antioxidants have been exploited in recent years for their actual or supposed beneficial effect against oxidative stress, such as vitamin E, flavonoids, and polyphenols. While we tend to describe oxidative stress just as harmful for human body, it is true as well that it is exploited as a therapeutic approach to treat clinical conditions such as cancer, with a certain degree of clinical success. In this review, we will describe the most recent findings in the oxidative stress field, highlighting both its bad and good sides for human health.

12 March 2014 in European Geriatric Medicine
Verified
Journal Article
Closed access
Giorgio BasileGiorgio Basile
Giorgio Basile
ACA. Crucitti
A. Crucitti
MCMaria Cucinotta
Maria Cucinotta
ALAntonio Lacquaniti
Antonio Lacquaniti
Antonino CatalanoAntonino Catalano
Antonino Catalano
ALA. Lasco
A. Lasco

1 January 2013 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
ACAngelina Cistaro
Angelina Cistaro
Natale QuartuccioNatale Quartuccio
Natale Quartuccio
AMAlireza Mojtahedi
Alireza Mojtahedi
PFPiercarlo Fania
Piercarlo Fania
PFPier Luigi Filosso
Pier Luigi Filosso
SBSergio Baldari
Sergio Baldari
Purpose. To investigate the impact of the maximum standardized uptake value (SUVmax), size of primary lung lesion, and %ΔSUVmax on outcome (overall survival (OS) and 2‐year disease‐free survival (2‐year DFS)) of patients with advanced nonsmall‐cell lung cancer (NSCLC). Materials and Methods. 86 stage III‐IV NSCLC patients underwent 18 F‐FDGPET/CT, before and after chemotherapy, and were classified into subgroups according to the response criteria of the European Organization for Research and Treatment of Cancer. SUVmax values and tumor size with the best prognostic significance were searched. Correlation between the SUVmax value and the initial response to therapy (best response) and the relationship between %ΔSUVmax and OS were assessed. Results. In patients in PD (20/86), the average pretreatment SUVmax was 11.8 ± 5.23, and the mean size of the primary lesion was 43.35 mm ± 16.63. In SD, PR, and CR patients (66/86), the average pretreatment SUVmax was 12.7 ± 8.05, and the mean size of the primary lesion was 41.6 mm ± 21.15. Correlation was identified only for %ΔSUVmax; patients with PD (ΔSUVmax > +25%) showed a worse OS than patients with ΔSUVmax < +25% (CR, PR, and SD) (P = 0.0235). Conclusions. In stage III‐IV NSCLC, among the assessed factors, only %ΔSUVmax may be considered as a useful prognostic factor.